Lack of clinical evidence could hold back technology

Despite the growth in popularity and investments in healthcare technology over the past year, zero initial public offerings (IPOs) occurred in 2017.

According to Forbes, investment in health technology in 2017 exceeded $6 billion, so why are the number of IPOs so low? One barrier in the market could be the lack of data on a company's ability to provide valid clinical solutions.

Read the full story below:

Subscribe to Health Exec News

Cara Livernois
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Subscribe to Health Exec News

Subscribe to Health Exec News